Blog
Our holistic, in-house approach means that we generate insight in the real world in real time – giving new power to patients’ voices.
The robustness and scientific rigor of our studies, combined with the real-world, real-time evidence we capture, yield significant opportunities for rapid peer-reviewed publications.
Stay tuned for new content from our thought leaders.
Should we be assessing the impact of rare diseases on patients’ siblings?
As well as exploring the impact of diseases on patients, many of Vitaccess’ studies investigate the burden experienced by informal caregivers of...
How much does a real-world study cost?
How much does it cost to conduct a real-world study? This is a question we are often asked at Vitaccess. The answer is never straightforward, given...
What’s in store for 2024? Predictions and tips for real-world research
Thermo Fisher Scientific’s PPD clinical research business published a recent survey on predictions for biopharma and biotech industries in 20241....
Real from start to finish: making the most of real-world data from disease registries across the product lifecycle
As real-world evidence (RWE) is increasingly being used to inform guidance and approval decisions by regulators, health technology assessment (HTA)...
Key takeaways from ISPOR Europe 2023
[dipl_scroll_image image="https://vitaccess.com/wp-content/uploads/2023/11/Mktg_ISPOR_Blog_header_v2.jpg" _builder_version="4.23.1"...
The power of trial interviews
In October 2023, the US Food and Drug Administration (FDA) released their industry guidance for benefit-risk assessment of novel products¹, in which...
Why your immunology portfolio needs a patient-centered real-world study
Patient-centered real-world research should be an essential part of the evidence development strategy for an immunology portfolio. Here, we discuss...
Designing patient-centered registries to support regulatory decision-making
According to the FDA, a registry can be defined as “an organized system that collects clinical and other data in a standardized format for a...
Below the surface: NICE’s quality standards in skin cancer
The National Institute for Health and Care Excellence (NICE) is developing guidance to update the quality standard in skin cancer, which covers the...
Ethics in patient-centered real-world studies: what, when, and who?
What do we mean by ethics? Ethics are principles or standards that guide behavior. Aligning research processes to ethical guidelines protects...
From paper to screen: eCOAs and the ISPOR Task Force’s updated recommendations
Electronic formats of clinical outcome assessments (eCOAs) have become the norm. COAs describe or reflect how a person feels, functions, or...
Data storytelling in patient-centric research
Mapping the patient journey: data storytelling in patient-centric research Harshitha Ravindra, Data Visualization Lead, and Laura Day, Associate...
Maximizing the potential of your digital patient-centric study
On March 29, we hosted the 15th webinar in our “Keeping it real” series: “How to design a study app for a real-world study”. Jon Spinage, CTO, and...
Are you getting your message across? Health literacy in real-world research
Health literacy is the degree to which individuals have the ability to find, understand, and use information and services to inform health-related...
Designing a digital patient-reported real-world study
On 25th January, we hosted the 13th webinar in the “Keeping it real” series. How to design a digital real-world study? Real-World Evidence...
Delphi panels and the case for consensus
In the hierarchy of evidence, randomized controlled trials are the gold standard. While seeking expert opinion will never compare in terms of...
Reflecting on 2022, and looking into the (RWE) crystal ball…
Future historians are likely to look back on 2022 as a year of political, economic, and climatic turbulence… as the year winds down, however, the...
Should I stay or should I go? Patient engagement and retention in real-world studies
In April 2022, Industry Standard Research conducted a survey on behalf of PPD (the clinical research business of Thermo Fisher Scientific) with 152...
Micro-moments: how and why to capture them with RWD
This blog is based on a webinar hosted by Vitaccess. For access to this webinar, and all webinars that we have hosted, please visit our dedicated...
Real-world data to support access for medical devices
This blog is based on a webinar hosted by Vitaccess in collaboration with Odelle Technology. Odelle Technology is an established consultancy...
Translation of ethnicity lists in multi-country real-world studies
When entering demographic information, participants registering for multi-country real-world studies typically select their ethnicity from a...
How to overcome obstacles in RWE analytics
Analyzing datasets from our clients’ real-world studies can be complicated. The nature of these studies, and what sets them apart from randomized...
It’s good to talk: the value of qualitative research
People experience things in a unique way, using their own words and meanings to make sense of what is going on around them. In the case of a health...
How to build a scientific advisory board for digital registries
Scientific advisory boards (SABs) are an important part of the governance framework for digital real-world studies. These studies are conceptualized...
Why is UX a priority in digital real-world studies?
When we talk about “user experience” or “UX”, what do we mean? Creating products for patients carries unique and important challenges. Even within a...
Why is the caregiver perspective more important than ever in real-world studies?
On March 2, 2022, we held a webinar on the importance of including the caregiver perspective in real-world studies. Here, we delve into some of the...
NICE severity modifier: Not all QALYs are created equal
The UK's National Institute for Health and Care Excellence (NICE) has published an update to its methods and processes for health technology...
